Hein Schepers

2.3k citations

34 papers · 1.4k indexed · 1 hit paper · h-index 21

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Cancer Research top 10%
- NF-κB Signaling Pathways

Papers in ⓘ

Molecular Biology 20
- Epigenetics and DNA Methylation 7
- Renal and related cancers 3
- Cell death mechanisms and regulation 3
Hematology 19
- Acute Myeloid Leukemia Research 17
- Hematopoietic Stem Cell Transplantation 5

Co-authors: Edo Vellenga (19 shared papers)Jan Jacob Schuringa (10 shared papers)Bart J. L. Eggen (6 shared papers)Albertus T.J. Wierenga (5 shared papers)Marjan Geugien (6 shared papers)Djoke van Gosliga (3 shared papers)Mario Mauthe (1 shared paper)Philip V’kovski (1 shared paper)
Journals: Experimental Hematology (6 papers)Blood (6 papers)Leukemia (3 papers)Transfusion (1 paper)Cell Death and Disease (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Hein Schepers

34 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle 2019 · 265 citations

Peers

Countries citing papers authored by Hein Schepers

Since Specialization

Citations

This map shows the geographic impact of Hein Schepers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hein Schepers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hein Schepers more than expected).

Fields of papers citing papers by Hein Schepers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hein Schepers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hein Schepers. The network helps show where Hein Schepers may publish in the future.

Co-authors

The 25 scholars most cited alongside Hein Schepers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hein Schepers Line = papers co-authored together Hein Schepers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle Journal of Virology ·Yingying Cong, Mustafa Ulaşlı, Hein Schepers, Mario Mauthe, Philip V’kovski, Franziska Kriegenburg, Volker Thiel, Cornelis A. M. de Haan, Fulvio Reggiori Hit paper breakdown →	2019	265
2	Constitutive NF-κB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway Leukemia ·Kim U. Birkenkamp, Marjan Geugien, Hein Schepers, Jeroen M. Westra, H.H. Lemmink, Edo Vellenga	2003	110
3	Ser727‐dependent transcriptional activation by association of p300 with STAT3 upon IL‐6 stimulation FEBS Letters ·Jan-Jacob Schuringa, Hein Schepers, Edo Vellenga, W. Kruijer	2001	107
4	STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells Blood ·Hein Schepers, Djoke van Gosliga, Albertus T.J. Wierenga, Bart J. L. Eggen, Jan Jacob Schuringa, Edo Vellenga	2007	85
5	Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells Cell stem cell ·Kamil R. Kranc, Hein Schepers, Neil P. Rodrigues, Simon D. Bamforth, Ellen Villadsen, Helen Ferry, Tiphaine Bouriez‐Jones, Mikael Sigvardsson, Shoumo Bhattacharya, Sten Eirik W. Jacobsen, Tariq Enver	2009	81
6	Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells Experimental Hematology ·Djoke van Gosliga, Hein Schepers, Aleksandra Rizo, Dorina van der Kolk, Edo Vellenga, Jan Jacob Schuringa	2007	71
7	Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations Surgery ·Jeroen DeGroot, Iván Plaza-Menacho, Hein Schepers, L. J. Drenth-Diephuis, J. Osinga, J PLUKKER, Thera P. Links, Bart J. L. Eggen, Robert M.W. Hofstra	2006	51
8	CoA‐dependent activation of mitochondrial acyl carrier protein links four neurodegenerative diseases EMBO Molecular Medicine ·Roald A. Lambrechts, Hein Schepers, Yi Yu, Marianne van der Zwaag, Kaija J. Autio, Marcel A. Vieira‐Lara, Barbara M. Bakker, Marina A.J. Tijssen, Susan J. Hayflick, Nicola A. Grzeschik, Ody C.M. Sibon	2019	48
9	The TAK1-NF-κB axis as therapeutic target for AML Blood ·Matthieu Bosman, Hein Schepers, Jennifer Jaques, Annet Z. Brouwers-Vos, Wim J. Quax, Jan Jacob Schuringa, Edo Vellenga	2014	48
10	Reintroduction of C/EBPα in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis Blood ·Hein Schepers, Albertus T.J. Wierenga, Djoke van Gosliga, Bart J. L. Eggen, Edo Vellenga, Jan Jacob Schuringa	2007	41
11	STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPα Blood ·Albertus T.J. Wierenga, Hein Schepers, Malcolm A.S. Moore, Edo Vellenga, Jan Jacob Schuringa	2006	39
12	Constitutive cytoplasmic localization of p21Waf1/Cip1 affects the apoptotic process in monocytic leukaemia Leukemia ·Hein Schepers, Marjan Geugien, Bart J. L. Eggen, Edo Vellenga	2003	38
13	HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun Experimental Hematology ·Hein Schepers, Marjan Geugien, Marco van der Toorn, Anton L. Bryantsev, Harm H. Kampinga, Bart J. L. Eggen, Edo Vellenga	2005	37
14	Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy Critical Reviews in Oncology/Hematology ·Katharina Mattes, Edo Vellenga, Hein Schepers	2019	36
15	Ex Vivo Assays to Study Self-Renewal and Long-Term Expansion of Genetically Modified Primary Human Acute Myeloid Leukemia Stem Cells Methods in molecular biology ·Jan Jacob Schuringa, Hein Schepers	2009	32
16	Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases Experimental Hematology ·Szabolcs Fátrai, Hein Schepers, Henko Tadema, Edo Vellenga, Simon Daenen, Jan Jacob Schuringa	2008	29
17	STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells PubMed ·Hein Schepers, Albertus T.J. Wierenga, Edo Vellenga, Jan Jacob Schuringa	2012	28
18	Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT Blood ·Gerbrig Berger, Leonie I. Kroeze, Theresia N. Koorenhof‐Scheele, Aniek O. de Graaf, Kenichi Yoshida, Hiroo Ueno, Yuichi Shiraishi, Satoru Miyano, Eva van den Berg, Hein Schepers, Bert A. van der Reijden, Seishi Ogawa, Edo Vellenga, Joop H. Jansen	2018	26
19	CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions Cell Reports ·Johannes Jung, Sonja Buisman, Ellen Weersing, Albertina Dethmers-Ausema, Erik Zwart, Hein Schepers, Mike R. Dekker, Seka Lazare, Franziska Hammerl, Yulia Skokova, Susanne M. Kooistra, Karin Klauke, Raymond A. Poot, Leonid Bystrykh, Gerald de Haan	2019	25
20	CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia Leukemia ·Patrick M. Korthuis, Gerbrig Berger, Björn Bakker, Marjan Rozenveld-Geugien, J Jaques, Gerald de Haan, Jan Jacob Schuringa, Edo Vellenga, Hein Schepers	2014	24

About Hein Schepers

Hein Schepers is a scholar working on Molecular Biology, Hematology, Oncology, Epidemiology and Immunology, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Epigenetics and DNA Methylation (7 papers), Cytokine Signaling Pathways and Interactions (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), NF-κB Signaling Pathways (4 papers), Renal and related cancers (3 papers), Neurological diseases and metabolism (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Hematology (442 citations), Cancer Research (206 citations), Infectious Diseases (221 citations), Genetics (117 citations) and Molecular Biology (752 citations). Hein Schepers has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Edo Vellenga, Jan Jacob Schuringa, Bart J. L. Eggen, Albertus T.J. Wierenga, Marjan Geugien, Djoke van Gosliga, Mario Mauthe, Philip V’kovski, Fulvio Reggiori and Yingying Cong. Their work appears in journals such as Experimental Hematology, Blood, Leukemia, Transfusion and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact